Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer
John P. Crown, Véronique Diéras, Elzbieta Staroslawska, Denise A. Yardley, Thomas Bachelot, Neville Davidson, Hans Wildiers, Peter A. Fasching, Olivier Capitain, Manuel Ramos, Richard Greil, Francesco Cognetti, George Fountzilas, Maria Blasinska-Morawiec, Cornelia Liedtke, Rolf Kreienberg, Wilson H. Miller, Vanessa Tassell, Xin Huang, Jolanda Paolini
*Corresponding author for this work
- Irish Cooperative Oncology Research Group
- Institut Curie
- Centrum Onkologii Ziemi Lubelskiej
- Sarah Cannon Research Institute
- Centre Leon Berard
- Mid Essex Hospital Services
- KU Leuven
- University of Erlangen–Nuremberg
- Centre Paul Papin
- Centro Oncologico de Galicia
- Paracelsus Medical University
- Istituto Regina Elena
- Aristotle University of Thessaloniki, Greece.
- Wojewodzki Szpital Specjalistyczny
- University of Ulm
- Segal Cancer Centre of Jewish General Hospital
- McGill University
- Pfizer Inc.
- Regional Centre for the Fight Against Cancer Val d'Aurelle Paul-Lamarque
- Institut Régional du Cancer de Montpellier (ICM)
133
Link opens in a new tab
Citations
(Scopus)